**vo
**rdisk to end
German sales of new
insulin drug after price row
COPENHAGEN (Reuters) - Denmark's
**vo **rdisk, the world's biggest
insulin producer, is to stop selling its new long-acting
insulin drug Tresiba in Germany following a row over pricing.


